Guadalupe García-Tsao, MD Professor of Medicine Yale University. Chief, Digestive Diseases Section VA-CT Healthcare System.

Size: px
Start display at page:

Download "Guadalupe García-Tsao, MD Professor of Medicine Yale University. Chief, Digestive Diseases Section VA-CT Healthcare System."

Transcription

1 1 Management of Guadalupe García-Tsao, MD Professor of Medicine Yale University Chief, Digestive Diseases Section VA-CT Healthcare System I have no disclosures to make relative to my presentation. CIRRHOSIS IS THE MOST COMMON CAUSE OF ASCITES Cirrhosis is the Most Common Cause of Peritoneal malignancy Cirrhosis Heart failure Peritoneal tuberculosis Others Pancreatic Budd-Chiari syndrome Nephrogenic ascites Source of the main 3 causes of ascites Entity Source Pathophysiology Cirrhosis Hepatic sinusoid Fibrosis Patients and with nodules cirrhotic ascites causing have sinusoidal an HVPG and of at post-sinusoidal least 12 mmhg (nl 3-5) obstruction Morali et a. J Hepatol 22 Heart failure Hepatic sinusoid Congestion of liver due to right heart failure (posthepatic block) Peritoneal malignancy/tb Peritoneum Inflammation or infiltration of the peritoneum

2 2 Rationale Behind the Serum- Albumin Gradient (SAAG) (out of the sinusoid) (into the sinusoid) SIN hyd + PER onc = SIN onc + PER hyd SIN hyd = SIN onc - PER onc HVPG = Serum albumin - = SAAG albumin The Serum- Albumin Gradient (SAAG) Correlates With Sinusoidal Pressure 3 2 HVPG (mmhg) 11 1 r = SAAG (g/dl) 1.1 Hoefs J, J Lab Clin Med 1983; 12:26 Serum- Albumin Gradient and Protein Levels in the Most Common Causes of Serum ascites 2. albumin gradient (g/dl) 1. SERUM-ASCITES ALBUMIN GRADIENT (SAAG) AND ASCITES PROTEIN LEVELS IN THE MOST COMMON CAUSES OF ASCITES SAAG is an indicator of sinusoidal pressure. If >1.1 ascites is coming from the sinusoid Cirrhotic ascites Cardiac ascites Peritoneal malignancy

3 3 THE PERMEABILITY OF THE HEPATIC SINUSOID VARIES IN HEALTH AND DISEASE The Permeability of the Hepatic Sinusoid Varies in Health and Disease no basement membrane Hepatocytes The normal sinusoid is leaky Sinusoid fibrous tissue deposition capillarization of sinusoid In cirrhosis, the hepatic sinusoid is less leaky Sinusoid Serum- Albumin Gradient and Protein Levels in the Most Common Causes of Serum ascites 2. albumin gradient (g/dl) 1. SERUM-ASCITES ALBUMIN GRADIENT (SAAG) AND ASCITES PROTEIN LEVELS IN THE MOST COMMON CAUSES OF ASCITES SAAG is an indicator of sinusoidal pressure. If >1.1 ascites is coming from the sinusoid 1.1 Ascitic fluid total protein (g/dl) Cirrhotic ascites Runyon, Ann Intern Med 1992; 117:215 Cardiac ascites Peritoneal malignancy (75) 2.5 protein is an indicator of leakiness of sinusoid, >2.5 the sinusoid is leaky (i.e. normal) SAAG and ascites total protein can establish the differential among the main causes of ascites CONDITION Cirrhosis Peritoneal malignancy Heart failure SAAG high low high ASCITES PROTEIN low high high Cutoff 1.1 g/dl 2.5 g/dl

4 4 Serum BNP has a higher diagnostic accuracy for cardiac ascites than SAAG/ascites protein Rules in Rules out Test LR (+) (rules in) SAAG >1.1; prot > LR(-) (rules out) Serum BNP >364 pg/ml SAAG <1.1; prot < Serum BNP < 182 pg/ml. Patients with new onset ascites Farias et al. Hepatology 214; 59: Natural History of Chronic Liver Disease Chronic liver disease Compensated cirrhosis Decompensated cirrhosis VH Encephalopathy Death VH= variceal hemorrhage In a cohort of patients with compensated cirrhosis, ascites was the most common decompensating event Decompensation.5.25 VH HE Jaundice months D Amico G. Gastroenterology 21; 12: A2

5 5 Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Splanchnic / systemic vasodilatation Effective arterial blood volume Diuretics Sodium retention Activation of neurohumoral systems SPIRONOLACTONE IS MORE EFFECTIVE THAN FUROSEMIDE IN CIRRHOTIC PATIENTS WITH ASCITES Spironolactone is More Effective Than Furosemide in Uncomplicated Response No response Total Spironolactone (15-3 mg/d) Furosemide (8-16 mg/d) Perez-Ayuso et al. Gastroenterology 1983; 84:961 Treatment of ascites Not an emergency, treat ascites in a stepwise unhurried manner Other complications (GI bleed AKI, infection) are absent or have resolved If patient uncomfortable large volume paracentesis Treatment aimed at achieving a negative sodium balance

6 6 Less frequent dose reductions are needed when spironolactone is started alone Spironolactone alone* (n=5) Spironolactone + Furosemide (n=5) Response Rate 94% 98% Time to Response 12.8 days 12.3 days Dose reduction needed 34% p=.2 68% Santos et al., J Hepatol 23; 39:187 * Followed by furosemide if necessary In addition to spironolactone-based diuretics. Salt restriction (2g/day = ~9mEq/day) Do not compromise nutritional status Avoid non-steroidal anti-inflammatory drugs No water restriction unless serum Na <13 meq/l Low threshold to perform a diagnostic paracentesis to investigate SBP Management of Follow weight and labs (BUN, creatinine, lytes) Weight loss goals 2-3 lb a week; no more than 1 lb / day If no weight loss Make sure patient is not on NSAIDs Check urine Na. If any of the following, patient is eating too much salt: > 5 meq/l or greater than daily Na intake Spot UNa >UK (correlates with a 24-hour sodium excretion >78 meq/l)

7 7 Hepatic Hydrothorax Occurs in ~6% of patients with cirrhosis Krok KL, Cardenas A. Semin Respir Crit Care Med 212; 33: 3-1. Due to transdiaphragmatic movement of fluid from the peritoneum to the pleural space through diaphragmatic defects Management same as for cirrhotic ascites Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Splanchnic / systemic vasodilatation Effective arterial blood volume Activation of neurohumoral systems Sodium retention Refractory Large volume-paracentesis (LVP): Local therapy Recurrence of ascites is the rule May be associated with postparacentesis circulatory dysfunction

8 8 LVP WITHOUT ALBUMIN LEADS TO INCREASES INCIDENCE OF POST-PARACENTESIS CIRCULATORY DYSFUNCTION (PCD) LVP Without Albumin Leads to Increases in Renin, Renal Failure and Hyponatremia Plasma renin activity (ng/ml/h) ns p<.1 Postparacentesis circulatory dysfunction (PCD) % Renal failure / Hyponatremia p<.1 Before After Albumin Before After No albumin Albumin No albumin Gines et al., Gastroenterology 1988; 94:1493 CONSEQUENCES OF POST-PARACENTESIS CIRCULATORY DYSFUNCTION (PCD) Consequences of post-paracentesis circulatory dysfunction (PCD) Shorter time to ascites recurrence Higher incidence of hyponatremia and renal dysfunction Higher mortality Gines et al., Gastroenterology 1996; 111:12; Ruiz del Arbol et al., Gastroenterology 1997; 113:579 Post-paracentesis circulatory dysfunction (PCD) is lowest in patients receiving albumin after LVP % Development of PCD No expander Saline Synthetic expander Albumin* 1 Overall Gines et al., Gastroenterology 1988; 94:1493; Gines et al., Gastroenterology 1996; 111:12; Sola-Vera et al., Hepatology 23; 37:1147 <5-6 L >5-6 L removed *6-8 g per liter of ascites removed

9 9 Cirrhosis Intrahepatic resistance Portal (sinusoidal) hypertension Other volume expanders? Vasoconstrictors? LVP Splanchnic / systemic vasodilatation Effective arterial blood volume ALBUMIN Activation of neurohumoral systems Sodium retention Water retention Renal vasoconstriction Refractory Hyponatremia Hepatorenal syndrome Compared to alternative treatment, albumin reduces the rate of PCD Favors albumin Favors control Bernardi et al. Hepatology 212;55:1172. Recurrence of ascites is no different in patients treated with LVP + albumin vs. octreotide/midodrine PCD : 18% (2/11) with Albumin 25% (2/8) with Octreotide/Midodrine (p=.574) Bari et al. Accepted Clin Gastroenterol Hepatol.

10 1 THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT Transjugular Intrahepatic Portosystemic Shunt Hepatic vein TIPS Portal vein Splenic vein Superior mesenteric vein In Lebrec refractory (1996) 2 ascites, TIPS is more effective than LVP in preventing ascites recurrence Recurrence of ascites.14 (.8-.26) Encephalopathy Death Death (excluding Lebrec) 2.34 ( ).9 ( ) Heterogeneity 2 p=.5.74 ( ) Better TIPS Better LVP Odds ratio D Amico et al. Gastroenterology 25; 129:1282 In a meta-analysis of individual patient data, survival was better with TIPS than LVP Survival Encephalopathy p=.36 P=.5 Greater survival benefit in patients treated with TIPS who had a MELD score <15 TIPS= transjugular intrahepatic portosystemic shunt LVP= large-volume paracentesis *individual data meta-analysis Salerno et al. Gastroenterology 27;133:

11 11 Refractory hepatic hydrothorax A trial of in-hospital diuretic therapy should be attempted Serial thoracenteses may be required too frequently Chest tube or indwelling catheter should not be placed ( infection, AKI) TIPS may need to be considered earlier Clinical response (67%) and survival are also associated with pre-tips MELD <15 Dhanasekaran et al. Am J GE 21. Peritoneo-Venous Shunt (PVS) is Useful in the Treatment of Refractory Use of jugular vein will hinder TIPS placement Indicated in malignant ascites or patients who are not transplant or TIPS candidates One-way valve Intraabdominal adhesions may complicate liver transplant surgery Pilot safety study of Automated Low-Flow pump for refractory (ALFA) (n=4) ALFA pump transfers ascites into the bladder Placed under general anesthesia 6-month followup LVP per month Infections antibiotic prophylaxis (76% 42%) Catheter dislodgement/problems (1/4=25%) Surgical complications (5/4) Progressive decrease in serum albumin 13 early termination, 8 died, 2 txp Bellot et al. J Hepatol 213;58:922-7

12 12 In patients with large varices that have not bled, a decrease in HVPG >1% leads to less ascites, RA and HRS Refractory ascites Hepatorenal syndrome Hernandez-Gea et al. Am J Gastroenterol 212; 17: Cirrhotic ascites The most common decompensating event in cirrhosis It is not an emergency unless complicated by infection or hepatorenal syndrome Ideal treatment strategies should be based on its pathophysiology Increase sodium excretion Decrease sinusoidal pressure Remove fluid while replenishing intravascular volume

Evaluation and Prognosis of Patients with Cirrhosis

Evaluation and Prognosis of Patients with Cirrhosis Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded

More information

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis

More information

MANAGEMENT OF LIVER CIRRHOSIS

MANAGEMENT OF LIVER CIRRHOSIS MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different

More information

June 11, 2015 Tim Halterman

June 11, 2015 Tim Halterman June 11, 2015 Tim Halterman Defini&on Histologic change + loss of liver function Derives from Greek word kirrhos meaning yellow, tawny First named by Rene Laennec in 1819 Laennec s cirrhosis=alcoholic

More information

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D. 1 COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST COMPLICATIONS OF CIRRHOSIS Philip C. Delich, M.D. Faculty Disclosure Dr. Delich has indicated that he does not have any relevant financial

More information

COMPLICATIONS OF CIRRHOSIS: CASES. Anil Seetharam, MD Anil.Seetharam@bannerhealth.com

COMPLICATIONS OF CIRRHOSIS: CASES. Anil Seetharam, MD Anil.Seetharam@bannerhealth.com COMPLICATIONS OF CIRRHOSIS: CASES Anil Seetharam, MD Anil.Seetharam@bannerhealth.com Defining Cirrhosis Histological diagnosis Nodules of regenerating hepatocytes surrounded by fibrous tissue Common final

More information

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco

More information

Perspective End-Stage Liver Disease in HIV Disease

Perspective End-Stage Liver Disease in HIV Disease Perspective End-Stage Liver Disease in HIV Disease Liver disease is the most common non AIDS-related cause of mortality in HIV-infected patients. HIV-infected patients with chronic liver disease progress

More information

CASE REPORT. T. L. Krishnamoorthy 1, M. Taneja 2 & P. E. Chang 1. Key Clinical Message

CASE REPORT. T. L. Krishnamoorthy 1, M. Taneja 2 & P. E. Chang 1. Key Clinical Message CASE REPORT Symptomatic hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt (TIPS) role of titration of portosystemic gradient reduction to avoid post- TIPS encephalopathy

More information

Complications of Cirrhosis

Complications of Cirrhosis Complications of Cirrhosis What is Cirrhosis? Paul J. Gaglio, MD Center for Liver Disease and Transplantation Columbia University College of Physicians and Surgeons NAFLD 1 Decreased clearance of Estrogen

More information

Cirrhosis and HCV. Jonathan Israel M.D.

Cirrhosis and HCV. Jonathan Israel M.D. Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment

More information

a series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION

a series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION www.hcvadvocate.org HCSP FACT SHEET Symptoms & Complications of Cirrhosis Foreword After many years of infection with hepatitis C the liver can become severely scarred. The process starts with inflammation

More information

Pathophysiology of Portal Hypertension

Pathophysiology of Portal Hypertension Pathophysiology of Portal Hypertension Jaime Bosch, M.D. Professor of Medicine, University of Barcelona Liver Unit, Hospital Clínic-IDIBAPS, Centro de Investigación Biomédica de Enfermedades Hepáticas

More information

Screening for Varices and Prevention of Bleeding

Screening for Varices and Prevention of Bleeding Hepatitis C Online PDF created August 24, 2016, 3:30 am Screening for Varices and Prevention of Bleeding Module 3: Lesson 3: Contents: Management of Cirrhosis-Related Complications Screening for Varices

More information

Acute on Chronic Liver Failure: Current Concepts. Disclosures

Acute on Chronic Liver Failure: Current Concepts. Disclosures Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures

More information

CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS

CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS LUCIAN BLAGA UNIVERSITY OF SIBIU VICTOR PAPILIAN FACULTY OF MEDICINE CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS Ph.D. THESIS SUMMARY COORDINATOR: PROF.DR. MANIŢIU IOAN Ph.D. STUDENT: LORENA MĂRIEŞ SIBIU

More information

NUTRITION IN LIVER DISEASES

NUTRITION IN LIVER DISEASES NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV

More information

Complications of Chronic Liver Disease

Complications of Chronic Liver Disease Complications of Chronic Liver Disease By Rima A. Mohammad, Pharm.D., BCPS Reviewed by Paulina Deming, Pharm.D.; Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS; and Kelly S. Bobo, Pharm.D., BCPS Learning

More information

A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation.

A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. Three years ago he was treated with 24 weeks of peginterferon alfa-2a (180 µg/wk, PEGIFN)

More information

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical

More information

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs

Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi

More information

The State of the Liver in the Adult Patient after Fontan Palliation

The State of the Liver in the Adult Patient after Fontan Palliation The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital

More information

TransplantUpdate. A Report From Baylor Regional Transplant Institute Volume 2 Number 1

TransplantUpdate. A Report From Baylor Regional Transplant Institute Volume 2 Number 1 TransplantUpdate A Report From Baylor Regional Transplant Institute Volume 2 Number 1 Treatment of Ascites 2 Ascites the accumulation of fluid in the abdominal cavity is the most common complication of

More information

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT

PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON

More information

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic

More information

Approach to Abnormal Liver Tests

Approach to Abnormal Liver Tests Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School

More information

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)

More information

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.

Program Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals. 1 Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the

More information

Significance of Serum Ascites Albumin Gradient and Ascitic Fluid Cholesterol in Classification of Ascites

Significance of Serum Ascites Albumin Gradient and Ascitic Fluid Cholesterol in Classification of Ascites ORIGINAL ARTICLE Significance of Serum Ascites Albumin Gradient and Ascitic Fluid Cholesterol in Classification of Ascites 1 B.Venugopal, 2 B.Sai Ravi Kiran, 3 G.Surya Prakash 4 E.Prabhakar Reddy ABSTRACT

More information

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US

More information

Liver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels

Liver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels Liver Failure Nora Aziz www.3bv.org Bones, Brains & Blood Vessels Severe deterioration in liver function Looses ability to regenerate/repair decompensated Liver extensively damaged before it fails Equal

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function

More information

Perspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know

Perspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know Perspective Advanced Liver Disease: What Every Hepatitis C Virus Treater Should Know Identification and treatment of advanced hepatitis C virus (HCV) infection is often challenging. Accurate fibrosis staging

More information

New Anticoagulants and GI bleeding

New Anticoagulants and GI bleeding New Anticoagulants and GI bleeding DR DANNY MYERS MD FRCP(C) CLINICAL ASSISTANT PROFESSOR OF MEDICINE, UBC Conflicts of Interest None I am unbiased in the use of NOAC s vs Warfarin based on risk benefit

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

PERITONEAL (ABDOMINAL) PARACENTESIS

PERITONEAL (ABDOMINAL) PARACENTESIS PERITONEAL (ABDOMINAL) PARACENTESIS Indications 1. To determine the cause of ascites. 2. To determine if ascites is infected. 3. For therapeutic removal of fluid: (a) (b) When distention is pronounced

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

1802 CLINICAL REVIEWS

1802 CLINICAL REVIEWS 1802 CLINICAL S nature publishing group Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center

More information

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32

Diseases of peritoneum Lect. Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Diseases of peritoneum Lect Al Qassim University, Faculty of Medicine Phase II Year III, CMD 332 Pathology Department 31-32 Describe the etiology, pathogenesis and types of peritonitis Define ascites and

More information

The use of TIPS in chronic liver disease

The use of TIPS in chronic liver disease Annals of Hepatology 2006; 5(1): January-March: 5-15 Concise Review Annals of Hepatology The use of TIPS in chronic liver disease Florence Wong 1 Abstract The development of cirrhosis and portal hypertension

More information

Cirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961

Cirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961 Cirrhosis and Ascites Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961 Overview Liver weighs about 3 pounds and is the largest organ in the body. It is located in the upper right side of the

More information

Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV

Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum

More information

The Management of Ascites and Hyponatremia in Cirrhosis

The Management of Ascites and Hyponatremia in Cirrhosis The Management of Ascites and Hyponatremia in Cirrhosis Pere Ginès, M.D., 1 and Andrés Cárdenas, M.D., M.M.Sc. 2 ABSTRACT Ascites is the most common complication of cirrhosis and is associated with an

More information

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 PRACTICE Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012 Bruce A. Runyon Jump to: Contents (click section title or page number) Recommendations and Rationales... 3 Full-text Guideline....56

More information

Renovascular Hypertension

Renovascular Hypertension Renovascular Hypertension Philip Stockwell, MD Assistant Professor of Medicine (Clinical) Warren Alpert School of Medicine Cardiology for the Primary Care Provider September 28, 201 Renovascular Hypertension

More information

Hemodynamic Disorders Edema, Hyperemia/Congestion, Hemorrhage

Hemodynamic Disorders Edema, Hyperemia/Congestion, Hemorrhage Michele D. Raible, M.D., Pharm.D. UIC College of Medicine Deputy Head for Pathology Education M2 Pathology Course Assistant Professor of Clinical Pathology,UIC Lecture #12 Phone: 312-996-7250 Monday, September

More information

Alcoholic Hepatitis (Teacher s Guide)

Alcoholic Hepatitis (Teacher s Guide) Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options

More information

Preoperative Laboratory and Diagnostic Studies

Preoperative Laboratory and Diagnostic Studies Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no

More information

Leading the Way to Treat Liver Cancer

Leading the Way to Treat Liver Cancer Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale

More information

Economic Impact of Treatment Options for Hepatic Encephalopathy

Economic Impact of Treatment Options for Hepatic Encephalopathy Economic Impact of Treatment Options for Hepatic Encephalopathy Carroll B. Leevy, M.D. 1 ABSTRACT Complications of chronic liver disease, such as hepatic encephalopathy (HE), can have a substantial impact

More information

AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis AASLD PRACTICE GUIDELINES Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis Guadalupe Garcia-Tsao, 1 Arun J. Sanyal, 2 Norman D. Grace, 3 William Carey, 4 and the

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy Cindy Goodrich RN, MS, CCRN Content Description Sepsis is caused by widespread tissue injury and systemic inflammation resulting

More information

Review. Current management of the complications of portal hypertension: variceal bleeding and ascites. bleeding. 20

Review. Current management of the complications of portal hypertension: variceal bleeding and ascites. bleeding. 20 Current management of the complications of portal hypertension: variceal bleeding and ascites Nina Dib, Frédéric Oberti, Paul Calès DOI:10.1503/cmaj.051700 Abstract Portal hypertension is one of the main

More information

Inpatient Heart Failure Management: Risks & Benefits

Inpatient Heart Failure Management: Risks & Benefits Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical

More information

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common

More information

Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension

Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Recanalized Umbilical Vein in the Presence of Cirrhosis-Induced Portal Hypertension Audrey Galey RDMS, RVT, Mary Grace Renfro RDSM, RVT, Lindsey Simon, RVT March 22, 2013 2 Abstract A recanalized umbilical

More information

Ascites refers to the pathologic accumulation of fluid within the peritoneal cavity. It is important

Ascites refers to the pathologic accumulation of fluid within the peritoneal cavity. It is important Approach to the Patient with Ascites Differential Diagnosis Ascites refers to the pathologic accumulation of fluid within the peritoneal cavity. It is important to establish a cause for its development

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor

More information

Clinical Aspects of Hyponatremia & Hypernatremia

Clinical Aspects of Hyponatremia & Hypernatremia Clinical Aspects of Hyponatremia & Hypernatremia Case Presentation: History 62 y/o male is admitted to the hospital with a 3 month history of excessive urination (polyuria) and excess water intake up to

More information

Liver, Gallbladder, Exocrine Pancreas KNH 406

Liver, Gallbladder, Exocrine Pancreas KNH 406 Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex

More information

FREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER

FREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER FREQUENCY OF PERITONEAL INFECTIONS AMONG PATIENTS UNDERGOING CONTINUOUS PARACENTESIS WITH AN INDWELLING CATHETER Abdul Nadir, David H Van Thiel* Maricopa Medical Centre, Phoenix AZ, *Division of Gastroenterology,

More information

THE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease. Dr Shahid A Khan. Case. Q for Discussion:

THE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease. Dr Shahid A Khan. Case. Q for Discussion: THE YELLOW PATIENT : Acutely Presenting Decompensated Chronic Liver Disease Topics we ll cover Alcoholic Hepatitis Ascites and Spontaneous Bacterial Peritonitis Hepatorenal Syndrome Hepatic Encephalopathy

More information

Liver Function Essay

Liver Function Essay Liver Function Essay Name: Quindoline Ntui Date: April 20, 2009 Professor: Dr. Danil Hammoudi Class: Anatomy and Physiology 2 Liver function The human body consist of many highly organize part working

More information

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.

More information

Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP. Amanda Tinning MN NP October 13, 2011

Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP. Amanda Tinning MN NP October 13, 2011 Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP Amanda Tinning MN NP October 13, 2011 Overview Define clinical outcomes Discuss the contributions of the NP role

More information

HEPATOLOGY CLERKSHIP

HEPATOLOGY CLERKSHIP College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,

More information

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo Educational Purpose: The Hepatology Rotation introduces the fellow to the management of outpatients and inpatients

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

Figure 1. Location of liver in the body. Figure 2. Clinical manifestations of portal hypertension

Figure 1. Location of liver in the body. Figure 2. Clinical manifestations of portal hypertension Portal Hypertension: Introduction As early as the 17th century, it was realized that structural changes in the portal circulation could cause gastrointestinal bleeding. In 1902, Gilbert and Carnot introduced

More information

Interpretation of Laboratory Values

Interpretation of Laboratory Values Interpretation of Laboratory Values Konrad J. Dias PT, DPT, CCS Overview Electrolyte imbalances Renal Function Tests Complete Blood Count Coagulation Profile Fluid imbalance Sodium Electrolyte Imbalances

More information

Assessing the risk of surgery in patients with liver disease

Assessing the risk of surgery in patients with liver disease REVIEW CME CREDIT AMITABH SUMAN, MD VA Medical Center and Shands Hospital at University of Florida, Gainesville WILLIAM D. CAREY, MD Director, Center for Continuing Education; Department of Gastroenterology,

More information

REVIEW CLINICAL REVIEWS

REVIEW CLINICAL REVIEWS 1802 CLINICAL S nature publishing group Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center

More information

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s! How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

Dehydration & Overhydration. Waseem Jerjes

Dehydration & Overhydration. Waseem Jerjes Dehydration & Overhydration Waseem Jerjes Dehydration 3 Major Types Isotonic - Fluid has the same osmolarity as plasma Hypotonic -Fluid has fewer solutes than plasma Hypertonic-Fluid has more solutes than

More information

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY 2 1 Mr N.N. 56 yr old male. Admitted on 22/03/02. 1 month Hx of abdominal distention, confusion, inability to concentrate and dyspnoea Grade 111. Pmx:

More information

Understanding Treatment Options for Renal Therapy

Understanding Treatment Options for Renal Therapy Understanding Treatment Options for Renal Therapy Kidney failure happens to many different people for many different reasons 1 What causes kidney failure? Diabetes Chronic infection High blood pressure

More information

Acid-Base Balance and the Anion Gap

Acid-Base Balance and the Anion Gap Acid-Base Balance and the Anion Gap 1. The body strives for electrical neutrality. a. Cations = Anions b. One of the cations is very special, H +, and its concentration is monitored and regulated very

More information

Saint Francis Kidney Transplant Program Issue Date: 6/9/15

Saint Francis Kidney Transplant Program Issue Date: 6/9/15 Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will

More information

The following should be current within the past 6 months:

The following should be current within the past 6 months: EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,

More information

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in

More information

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

The development of acute kidney injury (AKI) in

The development of acute kidney injury (AKI) in Acute Kidney Injury in Cirrhosis Guadalupe Garcia-Tsao, 1 Chirag R. Parikh, 2 and Antonella Viola 1,3 Acute renal failure (ARF), recently renamed acute kidney injury (AKI), is a relatively frequent problem,

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information

Ultrafiltration in PD: Physiologic Principles

Ultrafiltration in PD: Physiologic Principles Ultrafiltration in PD: Physiologic Principles Ali K. Abu-Alfa, MD, FASN Professor of Medicine Head, Division of Nephrology and Hypertension American University of Beirut Beirut, Lebanon Adjunct Faculty

More information

Cirrhosis: Diagnosis, Management, and Prevention

Cirrhosis: Diagnosis, Management, and Prevention : Diagnosis, Management, and Prevention S. PAUL STARR, MD, and DANIEL RAINES, MD, Louisiana State University Health Sciences Center School of Medicine at New Orleans, New Orleans, Louisiana Cirrhosis is

More information

Sepsis: Identification and Treatment

Sepsis: Identification and Treatment Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge

More information

Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. the diagnosis and evaluation of cirrhosis

Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. the diagnosis and evaluation of cirrhosis Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment JOEL J. HEIDELBAUGH, M.D., and MARYANN SHERBONDY, M.D. University of Michigan Medical School, Ann Arbor, Michigan Major complications

More information

Things You Don t Want to Miss in Multiple Myeloma

Things You Don t Want to Miss in Multiple Myeloma Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University

More information

Diagnostics: Page 2 of 5

Diagnostics: Page 2 of 5 Proteinuria Proteinuria is a condition in which there are increased amounts of protein in the urine. There are a number of different diseases which can result in proteinuria. In the early stages of the

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Living With Advanced Liver Disease

Living With Advanced Liver Disease 2014 Living With Advanced Liver Disease This book belongs to: repared by: Multi Organ Transplant rogram QEII Health Sciences Centre Halifax, NS Tel 902-473-1256 Fax 902-473-5898 Website: www.mydoctor.ca

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

S0140-6736(14)60121-5

S0140-6736(14)60121-5 Liver cirrhosis Emmanuel A Tsochatzis, Jaime Bosch, Andrew K Burroughs Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death

More information

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart

More information